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Fine needle aspiration (FNA) is currently accepted as an easy, safe, and reliable tool for the diag-
nosis of thyroid nodules. Nonetheless, a proportion of FNA samples are categorized into non-di-
agnostic or indeterminate cytology, which frustrates both the clinician and patient. To overcome 
this limitation of FNA, core needle biopsy (CNB) of the thyroid has been proposed as an addition-
al diagnostic method for more accurate and decisive diagnosis for thyroid nodules of concern. In 
this review, we focus on the effectiveness and limitations of CNB, and what factors should be 
considered when CNB is utilized in the diagnosis of thyroid nodules.
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At present, thyroid nodules are a common problem. With ad-
vances in diagnostic technology and the widespread usage of 
high-resolution ultrasonography (US), approximately 19%–67% 
of otherwise healthy, asymptomatic individuals will eventually be 
found to have thyroid nodules.1 Out of the vast amount of thy-
roid nodules detected, only 7%–16% of them will be eventually 
diagnosed as malignant.1 Therefore, an accurate and efficient di-
agnostic tool is critical for triaging patients with nodular disease 
of the thyroid. Fine needle aspiration (FNA), especially under US 
guidance, is considered the gold standard for differential diagno-
sis of thyroid nodules, due to its simplicity, safety, cost-effective-
ness, and diagnostic accuracy. Most authoritative guidelines rec-
ommend FNA for thyroid nodules detected on US as the next 
step in diagnosis.1,2 FNA has been reported to have diagnostic 
sensitivity of 83%–98% and specificity of 70%–92% by various 
studies.1-3
One major drawback of FNA is non-diagnostic and indeter-
minate cytology results (including atypia of undetermined sig-
nificance/follicular lesion of undetermined significance [AUS/
FLUS], follicular neoplasm or suspicious for a follicular neoplasm 
[FN/SFN], and suspicious for malignancy), which comprises ap-
proximately 10%–33.6% and 15%–42% of all FNA samples,4-7 
respectively. According to the Bethesda System for Reporting 
Thyroid Cytopathology,3 repeat ultrasonography-guided fine 
needle aspiration (US-FNA) is recommended for nodules with 
non-diagnostic or indeterminate cytology results, as repeat aspi-
ration provides conclusive results in most of these nodules. How-
ever, about 9.9%–50% of nodules with initial non-diagnostic 
cytology,8-10 and 38.5%–43% of nodules with indeterminate 
nodules11,12 will once again be diagnosed with inconclusive re-
sults, which induces frustration and anxiety in the patient and 
leads to confusion in patient management and additional diag-
nostic medical costs.
Core needle biopsy (CNB) of the thyroid gland has been pro-
posed as an additional diagnostic method to US-FNA, mainly to 
overcome the limitations of inconclusive cytologic diagnosis. 
CNB provides a large amount of tissue which enables histologic 
diagnosis, and additional immunohistochemical staining, if 
needed. Several studies have shown the usefulness of CNB in 
providing definitive diagnosis for thyroid nodules.12-15 Neverthe-
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less, there currently remains a lack of evidence and no definite 
guideline on how CNB should be used in the diagnosis of thy-
roid nodules. The American Association of Clinical Endocrinolo-
gists, Associazione Medici Endocrinologi, and European Thyroid 
Association (AACE/AME/ETA) guideline is the only authorita-
tive guideline that mentions using CNB, and only in selective 
cases with inadequate cytology,2 but the actual usage of CNB in 
clinical practice varies among institutions and radiologists. In 
this paper, we will review previous studies evaluating the diag-
nostic performance of CNB in order to discuss the effectiveness 
and limitations of CNB in the diagnosis of thyroid nodules.
EFFECTIVENESS
CNB in thyroid nodules with initial non-diagnostic cytology 
Although FNA has been established as an accurate diagnostic 
method for thyroid nodules by many authorized guidelines,1-3 
the diagnostic accuracy of FNA has been known to vary accord-
ing to (1) the experience of the operator, (2) intrinsic characteris-
tics of the targeted nodule, and (3) cytology interpretation.16 
These factors in particular, have significant influence on non-di-
agnostic cytology. As non-diagnostic aspirates are common causes 
of false-negative FNA results, the current guidelines recommend 
repeat FNA under US guidance,1-3 yet approximately 20.4%–
38.4% will once again be diagnosed as non-diagnostic.2,10 Sur-
gery is recommended for solid nodules with repeated non-diag-
nostic results for diagnostic purposes,1-3 which seems rather 
extreme when considering the relatively low malignancy rates 
(6.6%–39.5%) of nodules with non-diagnostic cytology.4,8,17 
Hence, CNB has been used as an adjunctive diagnostic tool in 
nodules with initial non-diagnostic cytology; recent studies have 
reported diagnostic or conclusive results in 86%–98.9% of non-
diagnostic nodules, and significantly lower non-diagnostic rates 
in CNB compared to repeat US-FNA (Table 1).12,13,15,17,18 In re-
ports that provide the diagnostic performances of CNB, high 
specificity and positive predictive values of 100% were com-
monly observed in CNB, suggesting that CNB enables malig-
nancy-specific results, even in nodules with prior non-diagnostic 
results. Higher diagnostic rates obtained with CNB are only 
natural since CNB can obtain larger tissue samples that provide 
histopathologic information of the targeted nodule and the sur-
rounding thyroid parenchyma. However, presently, only the 
AACE/AME/ETA guideline considers using US-CNB in “se-
lected cases with inadequate FNA results.”2 Otherwise, no spe-
cific recommendation or indications have been established on 
using CNB as a follow-up diagnostic tool in nodules with non-
diagnostic cytology. In addition, based on the low malignancy 
rates from repeat US-FNA (0.5%) or surgical resection (1.8%) 
in thyroid nodules with initial non-diagnostic cytology, a more 
conservative approach such as clinical or US follow-up has been 
proposed as a more appropriate alternative to additional invasive 
procedures such as follow-up FNA.19 Thus, the role of CNB in 
contributing meaningful information in non-diagnostic nodules 
is still unclear.
CNB in nodules with indeterminate cytology 
Indeterminate cytology, including AUS/FLUS, FN/SFN, and 
suspicious for malignancy categories of the Bethesda System for 
Reporting Thyroid Cytopathology,3 is a diagnostic challenge 
since it harbors a higher risk of malignancy (5%–75%) but not 
sufficiently high to directly consider surgery. There have been 
continual efforts to improve the accurate detection of malignan-
cy among these lesions, including US features and molecular 
analysis such as BRAF mutations.7,20 CNB has been utilized in 
the diagnosis of thyroid nodules with indeterminate cytolo-
gy;12,14,21-24 in most studies, CNB is used to direct indeterminate 
nodules to either surgery or conservative management. Park et al.21 
showed a high detection rate of benign nodules in CNB (77.8%), 
compared to repeat FNA (35.2%) and surgery (38.7%), with 
high diagnostic accuracy. In addition, inconclusive rates of CNB 
(17.6%) have been reported to be significantly lower than repeat 
FNA (37.3%) in another study which included AUS nodules.24 
Table 1. Results of the diagnostic performances of rFNA and CNB in thyroid nodules diagnosed as non-diagnostic on prior cytology 
Reference Total rFNA CNB rFNA-ND (%) CNB-ND (%)
Diagnostic performance of CNB
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Samir et al.18 (2012) 90 90 (100) 90 (100) 53 23 - - - - -
Na et al.12 (2012) 64 64 (100) 64 (100) 28.1 1.6 71.4 100 100 88.6 91.1
Yeon et al.15 (2013) 155 - 155 - 1.3 94.6 100 100 97.5 98.3
Lee et al.17 (2014) 514 389 (75.7) 125 (24.3) 33.2 2.4 70 100 100 97.3 -
Choi et al.13 (2014) 360 180 (50.0) 180 (50.0) 40.0 1.1 95.7 100 100 97.6 98.4
Values are presented as number (%) unless otherwise indicated.
rFNA, repeat fine needle aspiration; CNB, core needle biopsy; ND, non-diagnostic; PPV, positive predictive value; NPV, negative predictive value.
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This information facilitates accurate patient management and 
reduces unnecessary surgery.
Few studies have investigated the efficacy of US-CNB in the 
diagnosis of FN of the thyroid gland.23,25,26 CNB has been known 
to have advantages over FNA cytology in the diagnosis of FN in 
that the CNB specimen provides tissue samples which (1) visu-
alizes the microscopic monotonous follicular proliferation and 
presence of fibrous capsules, and (2) enables additional immuno-
histochemical staining for differential diagnosis. Nasrollah et al.26 
introduced a new biopsy technique that uses targeting to include 
the nodular tissue, surrounding fibrous capsule, and extranodu-
lar parenchyma; based on this method, a recent study demon-
strated the utility of CNB in preoperative diagnosis of FN with 
a significantly lower false-positive rate, unnecessary surgery rate, 
and higher malignancy rates compared to FNA.25 However, in 
contrast, Hakala et al.6 showed that while the sensitivity of CNB 
may be superior in the diagnosis of papillary thyroid carcinoma 
or other non-follicular thyroid lesions, CNB does not confer as 
much benefit as in the diagnosis of follicular tumors. Addition-
ally, a meta-analysis by Novoa et al.27 showed that FN was the 
reason for a high number of false-positive results from CNB in 
the thyroid when compared to other head and neck neoplasms, 
since CNB cannot differentiate between follicular adenoma and 
follicular carcinoma. Tissue sampling including obtaining an 
adequate amount of fibrous capsule and surrounding normal pa-
renchyma, which is required for the diagnosis of FN26 is not easy, 
even under US-guidance, and confounds the diagnosis between 
benign hyperplastic nodule and FN. In addition, for the diagno-
sis of follicular carcinoma, evaluation of the entire nodular cap-
sule is required to detect the presence of capsular/vascular inva-
sion, limiting the role of CNB as well as FNA as supported by 
the results of a prior study,23 which showed that although the di-
agnosis of neoplasm was significantly higher in CNB, the overall 
malignancy rates did not show significant differences between 
CNB and FNA (46% to 48%, respectively). Presently, even with 
its ability to provide larger tissue volume for additional immu-
nohistochemical staining, CNB, like FNA, has limited value in 
the differential diagnosis among subtypes of FN, serving only as 
a ‘screening test,’ rather than diagnostic for FN. Thus, CNB is 
not recommended for use in the differential diagnosis of FN since 
it does not provide additional diagnostic information, which is 
specified in the AACE/AME/ETA guidelines.2
CNB as a first-line diagnosis for thyroid nodules
At most institutions, CNB is used as a second-line diagnostic 
method, either as an adjunct or alternative to repeat FNA.5,12-
14,17,18,26,28 However, recently several studies have applied CNB in 
first-line diagnosis of thyroid nodules showing suspicious US 
features,29,30 concluding that CNB has high conclusive rates and 
reduces false-negative or inconclusive results of FNA in solid 
nodules that carry high levels of suspicion for malignancy. Both 
studies were from single institutions with a limited number of 
patients. More evidence from a large study population is war-
ranted before considering the application of CNB as a first-line 
Table 2. Inconclusive rates of CNB in published literature 
Reference Reason for CNB CNB-ND
CNB-AUS/
FLUS
CNB-FN/SFN
Total 
inconclusive
Khoo et al.31 (2008) Referred for CNB by clinicians - - - 37/320 (10.9)
Park et al.21 (2011) Prior indeterminate cytology 1/54 (1.8) - -    1/54 (1.8)
Sung et al.14 (2012) Previous non-diagnostic or indeterminate FNA result, 
  suspected malignancy with benign cytology results, 
  repeated scanty or bloody aspirates,
  thyroid malignancy other than differentiated cancer suspected
8/555 (1.4) 63/555 (11.4) 11/555 (2.0) 82/555 (14.8) 
Na et al.12 (2012) Prior ND cytology 1/64 (1.6) 7/64 (10.9)  6/64 (9.4) 14/64 (21.9)
Na et al.12 (2012) Prior AUS/FLUS cytology 5/161 (3.1) 38/161 (23.6) 8/161 (5.0) 51/161 (31.7) 
Ha et al.5 (2013) Suspicious US features, benign cytology 0/85 (0.0) 1/85 (1.2) 7/85 (8.2) 8/85 (9.4)
Yeon et al.15 (2013) Prior ND cytology 2/155 (1.3) 18/155 (11.6) 3/155 (1.9) 23/155 (14.8)
Lee et al.17 (2014) Prior ND cytology 3/125 (2.4) 5/125 (4.0) 11/125 (8.8) 19/125 (15.2)
Choi et al.22 (2014) Prior AUS cytology 1/84 (1.2) 13/84 (15.5) 5/84 (6.0) 19/84 (22.6)
Choi et al.22 (2014) Prior FLUS cytology 0/107 (0.0) 23/107 (21.5) 11/107 (10.3) 34/107 (31.8)
Choi et al.13 (2014) Prior ND cytology 2/180 (1.1) 11/180 (6.1) 3/180 (1.7) 16/180 (8.9)
Ha et al.32 (2014) Calcified nodules on US 2/272 (0.7) 25/272 (9.2) 12/272 (4.4) 39/272 (14.3)
Zhang et al.30 (2014) First-line diagnosis of thyroid nodules 4/369 (1.1) 7/369 (1.9) 11/369 (3.0) 22/369 (6.0)
Values are presented as number (%).
CNB, core needle biopsy; AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined significance; ND, non-diagnostic; FN/SFN, follicular 
neoplasm/suspicious for follicular neoplasm; FNA, fine needle aspiration; US, ultrasonography. 
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diagnostic tool.
Khoo et al.31 showed that no significant differences existed in 
the non-diagnostic rates between US-FNA alone and US-FNA 
combined to CNB, but there was a trend towards increased com-
plications in US-FNA combined to CNB. This study concluded 
that the addition of CNB to US-FNA does not decrease non-di-
agnostic results, and may only increase morbidity from the pro-
cedure. A recent meta-analysis by Li et al.33 showed similar re-
sults: the area under the receiving operator characteristics curves 
did not show significant differences between FNA (Az, 0.905) 
and CNB (Az, 0.745) in the preoperative diagnosis of thyroid 
nodules and Az values even lower in CNB. However, in some 
cases, especially in the diagnosis of lymphoma or anaplastic car-
cinoma, CNB has been reported to be helpful in specific diagno-
sis.28 Hence, the clinical and imaging features of the patient must 
also be considered when deciding which patients will benefit 
from CNB when applied in the diagnosis of thyroid lesions.
LIMITATIONS AND FURTHER CONSIDER-
ATIONS NEEDED FOR CORE NEEDLE BIOPSY
Complications from CNB
Commonly known complications that can occur after CNB 
are post-biopsy hematomas, bleeding from the incision site, pain, 
infections, transient hemoptysis, and nerve injuries.27,34,35 Report-
ed complication rates are low, ranging from 0.5%–1.0%,27 with 
similar patient tolerability and discomfort between FNA and 
CNB.36 However, CNB is not always technically feasible, espe-
cially in nodules located posteriorly or in close approximation to 
important structures such as the carotid artery or trachea. There-
fore, complications are bound to occur with CNB, even under 
US-guidance. Bergeron and Beaudoin34 reported an iatrogenic 
arteriovenous fistula formation after CNB causing tinnitus. From 
this case report, we can see that although complication rates are 
low, CNB can lead to severe and critical complications. While 
US-FNA may be more feasible for relatively less experienced op-
erators, CNB must be performed with experienced radiologists 
with dedicated training who are familiar with the radiologic fea-
tures of important anatomic structures within the cervical region 
to minimize major complications.
Inconclusive results on CNB
Based on the tissue samples obtained from CNB, higher con-
clusive rates are reported in the majority of the studies mentioned 
above. Even so, inconclusive results are unavoidable in thyroid 
CNB with reported rates ranging from 6.4%–26.7%,12,13,15,17,22,28 
reaching 31.8% when including FN in the inconclusive category 
(Table 2). As larger tissue samples are provided for histologic di-
agnosis, higher conclusive results are naturally expected. Yet, 
similar to FNA, a considerable proportion of thyroid nodules are 
once again diagnosed as inconclusive on CNB; in fact, a recent 
study from our institution suggested that 72.7% may be FN.37 
This is important and must always be considered when choosing 
CNB as the next step for thyroid nodules with prior inconclu-
sive results.
Lack of standardization in CNB pathologic classification
Management guidelines are established based on the clinical 
outcomes of non-diagnostic, AUS/FLUS, or FN/SFN cytology,1-3 
but currently, there are no reporting systems that can be used as 
a reference for CNB specimens as in the Bethesda System for 
Reporting Thyroid Cytopathology nor further management 
guidelines according to the diagnostic results from CNB. For ap-
propriate application of CNB in the diagnosis of thyroid nodules, 
a systematic diagnostic approach and definitive management 
guidelines need to be established first to minimize confusion on 
the indications for CNB and further management as needed.
CONCLUSION
CNB may have a complementary role to FNA especially in 
nodules with inconclusive cytologic diagnosis by providing de-
finitive diagnosis that helps to triage patients who need surgery 
and minimize unnecessary invasive procedures. CNB withholds 
a considerable proportion of inconclusive results which must be 
acknowledged. In addition, it must be performed by an experi-
enced radiologist to minimize severe complications from proce-
dures. There should be careful selection of patients who may ben-
efit from CNB. Ultimately, we must keep in mind that CNB is 
still a complementary diagnostic tool to FNA and not an alterna-
tive.
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